Over the past few weeks we have heard from many of our industry experts on what they see happening in 2023. From AI to equity, from security to risk, from payers to investors, and from innovation to transformation, here are some final thoughts.
Read More
At a truly unsustainable rate of national healthcare expenditures growing a 5.5% annually, will we be doing anything to bend the curve in 2023? Our predictions continue with healthcare financing.
Will we continue to make progress and implement initiatives that right the ship in 2023 when it comes to the population’s health and equity of care? Here are some predictions from the industry.
Drug pricing, CMS getting negotiating power for drug purchasing, vaccines, clinical trials, artificial intelligence, and Pharmacists becoming care givers. These are the highlights of 2022, what do the experts say we will see in 2023? We rounded up some experts and asked them just that.
The thought leaders in our community are good about sharing their thoughts on the issues of today. Here are the top read and shared guest posts of September that we think deserve sharing again.
By Liz Beatty – Tasked with reimagining patient-centric cancer clinical trials, the Bloomberg New Economy International Coalition has identified eliminating patient identification and enrollment barriers as top priorities.